Table 5.
Average values of statistically significant HDL-C and LDL-C sub-fractions in study groups, categorized according to the new AIP formula.
| Group I n = 16 |
Group II n = 36 |
p | |
|---|---|---|---|
| HDL1_1 | 5.13 ± 2.47 | 2.86 ± 2.40 | 0.003 ** |
| delta HDL1 | −1.50 ± 2.00 | 0.86 ± 2.60 | 0.002 ** |
| % change in HDL1 | −20.60 ± 41.17 | 56.90 ± 127.84 | 0.003 ** |
| HDL2_1 | 8.81 ± 3.04 | 6.69 ± 2.99 | 0.023 * |
| delta HDL2 | 0.19 ± 1.97 | 1.44 ± 2.06 | 0.045 * |
| % change in HDL2 | 3.43 ± 24.80 | 33.53 ± 46.49 | 0.019 * |
| delta HDL3 | 1.56 ± 1.86 | 2.92 ± 1.73 | 0.014 * |
| delta large HDL (1–3) | 0.69 ± 4.66 | 5.08 ± 4.16 | 0.001 ** |
| % change in large HDL (1–3) | 4.33 ± 26.36 | 52.32 ± 55.00 | ≤0.001 *** |
| HDL6_1 | 10.50 ± 1.67 | 12.61 ± 1.84 | ≤0.001 *** |
| HDL7_ | 3.56 ± 0.73 | 4.22 ± 0.93 | 0.015 * |
| delta HDL7 | 0.31 ± 0.70 | −0.39 ± 0.99 | 0.014 * |
| delta HDL8 | 0.25 ± 0.93 | −0.64 ± 1.22 | 0.013 * |
| delta HDL9 | 0.19 ± 0.91 | −0.58 ± 1.11 | 0.018 * |
| delta HDL10 | −0.13 ± 1.93 | −2.17 ± 3.01 | 0.016 * |
| delta small HDL | 0.38 ± 3.65 | −3.53 ± 4.44 | 0.003 ** |
| % change in small HDL | 8.99± 36.70 | −23.68± 31.77 | 0.002 ** |
| VLDL_1 | 32.38 ± 15.10 | 43.19 ± 18.71 | 0.047 * |
| delta VLDL | 2.56 ± 14.07 | −8.69 ± 11.42 | 0.004 ** |
| IDL-B_1 | 11.50 ± 5.49 | 15.39 ± 6.35 | 0.039 * |
| delta LDL1 | 8.81 ± 17.38 | −3.03 ± 17.53 | 0.029 * |
| LDL2_1 | 11.94 ± 11.28 | 21.67 ± 14.20 | 0.019 * |
| delta LDL2 | 4.06 ± 16.27 | −5.36 ± 11.76 | 0.022 * |
| LDL (1–2)1 | 53.69 ± 21.60 | 72.61 ± 25.08 | 0.012 * |
| delta LDL (1–2) | 12.88 ± 28.79 | −8.39 ± 23.77 | 0.007 ** |
| % change in LDL (1–2) | 50.06 ± 89.17 | −5.20 ± 28.69 | 0.027 * |
Group I: patients with increase in Atherogenic Index of Plasma—new formula; Group II: patients with decrease in Atherogenic Index of Plasma—new formula; p: p value of a two-sample t-test assuming or not assuming equal variances based on Levene’s Test for Equality of Variances; *: p ≤ 0.050; **: p ≤ 0.010; ***: p ≤ 0.001; _1: value before body mass reduction; _2: value after body mass reduction; HDL (1–10): high-density lipoprotein-cholesterol subfractions (1–10); large HDL: sum of large subfractions of high-density lipoprotein-cholesterol, subfractions (1–3); small HDL: sum of small subfractions of high-density lipoprotein-cholesterol, atherogenic subfractions (8–10); LDL (1–2): less atherogenic low-density lipoprotein-cholesterol subfractions (1–2); VLDL: very low-density lipoprotein; IDL-B: intermediate-density lipoprotein-cholesterol, subfraction B.